RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 267 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is 2.47 and the average weighting 0.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 11,905,668 | $89,292,510 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $29,633,558 | 44.95% |
| Data Collective IV GP, LLC | 5,941,120 | $44,558,400 | 31.23% |
| NVIDIA CORP | 7,706,363 | $57,797,723 | 14.70% |
| MIC Capital Management UK LLP | 8,451,758 | $63,388,186 | 13.78% |
| ARK Investment Management | 28,142,918 | $211,071,885 | 1.87% |
| RA Capital Management | 15,384,615 | $115,384,613 | 1.53% |
| COMMONS CAPITAL, LLC | 111,107 | $833,302 | 1.00% |
| ELEVATUS WELATH MANAGEMENT | 342,567 | $2,569,253 | 0.96% |
| Lingotto Investment Management LLP | 3,675,077 | $27,563,078 | 0.93% |
| Nikko Asset Management Americas, Inc. | 9,934,491 | $74,309,993 | 0.86% |
| Institute for Wealth Management, LLC. | 580,997 | $4,357,478 | 0.58% |
| Ghisallo Capital Management LLC | 1,100,000 | $8,250,000 | 0.58% |
| Carroll Investors, Inc | 80,766 | $605,745 | 0.42% |
| Mubadala Investment Co PJSC | 12,985,927 | $97,394,453 | 0.39% |
| Green Alpha Advisors, LLC | 62,999 | $472,492 | 0.38% |
| Cherry Creek Investment Advisors, Inc. | 93,338 | $700,035 | 0.36% |
| MARATHON CAPITAL MANAGEMENT | 175,220 | $1,314,150 | 0.34% |
| ALLEN OPERATIONS LLC | 217,657 | $1,632,428 | 0.32% |
| Monashee Investment Management LLC | 290,000 | $2,175,000 | 0.28% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q2 2024. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.